Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer

BACKGROUND: There are robust data supporting the contribution of oxaliplatin (L-OHP) regarding clinical outcomes for colorectal cancer (CRC) in an adjuvant setting in European and US trials; however, there is no Japanese clinical evidence although L-OHP has been approved since 2009. We examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Wakatsuki, Takeru, Nakayama, Izuma, Matsushima, Tomohiro, Ogura, Mariko, Ichimura, Takashi, Takahari, Daisuke, Chin, Keisho, Nagasaki, Toshiya, Konishi, Tsuyoshi, Akiyoshi, Takashi, Fujimoto, Yoshiya, Nagayama, Satoshi, Fukunaga, Yosuke, Ueno, Masashi, Yamaguchi, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451009/
https://www.ncbi.nlm.nih.gov/pubmed/28562679
http://dx.doi.org/10.1371/journal.pone.0176745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451009/
https://www.ncbi.nlm.nih.gov/pubmed/28562679
http://dx.doi.org/10.1371/journal.pone.0176745

Ejemplares similares